Plasma GFAP and NfL associate with cerebral glucose metabolism in putative brain-first and body-first Parkinson’s disease subtypes
Abstract The recently proposed body-first and brain-first subtypes are classified based on the initial localization of α-synuclein inclusions. This study investigated plasma biomarkers and cerebral glucose metabolism characteristics in putative brain-first and body-first subtypes in PD subjects. PD...
Saved in:
| Main Authors: | Shiyu Li, Fangyang Jiao, Xiuyuan Li, Zhiheng Xu, Tianyu Hu, Xiaoniu Liang, Jianjun Wu, Jian Wang, Chuantao Zuo, Yilin Tang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-03-01
|
| Series: | npj Parkinson's Disease |
| Online Access: | https://doi.org/10.1038/s41531-025-00898-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical applications and diagnostic research of GFAP and NfL in MS and NMOSD: a meta-analysis
by: XueJuan Lin, et al.
Published: (2025-07-01) -
CSF IL-6, GDF-15, GFAP and NfL levels in early Alzheimer disease: a pilot study
by: Domenico Plantone, et al.
Published: (2025-02-01) -
Evaluating plasma biomarkers NfL, GFAP, GDF15, and FGF21 as indicators of disease severity in Charcot–Marie Tooth patients
by: Dace Pretkalnina, et al.
Published: (2025-01-01) -
The role of Neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) in MS and AQP4-NMOSD: Advancing clinical applications.
by: Sara Samadzadeh, et al.
Published: (2025-03-01) -
Investigation of the association of serum GFAP and NfL with brain and upper cervical MRI volumes in AQP4-IgG-positive NMOSD and MOGAD
by: Patrick Schindler, et al.
Published: (2025-07-01)